Clinical Trial Update: Duodenal Exclusion for the Treatment of T2DM [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 clinical trial evaluating duodenal exclusion as a treatment for type 2 diabetes mellitus, sponsored by Medtronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Duodenal exclusion device

Snippet

Sponsor: Medtronic - MITG | Conditions: Diabetes | Phase 4 | Status: COMPLETED